William L. Brown

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Untangling prognosis in multiple sclerosis.

Untangling prognosis in multiple sclerosis.

Journal: Brain : a journal of neurology

Published: September 07, 2026

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 13, 2026

Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.

Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.

Journal: Therapeutic advances in neurological disorders

Published: November 11, 2025

Towards primary prevention of multiple sclerosis.

Towards primary prevention of multiple sclerosis.

Journal: Nature reviews. Neurology

Published: October 31, 2025

A database of geomagnetic observatory monthly means: from historic to the satellite era.

A database of geomagnetic observatory monthly means: from historic to the satellite era.

Journal: Earth, planets, and space : EPS

Published: August 22, 2025

Genetic subtypes associated with multiple sclerosis severity and response to treatment.

Genetic subtypes associated with multiple sclerosis severity and response to treatment.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: August 05, 2025

Serum neurofilament light chain levels suggest neuroprotection following bexarotene-induced remyelination in people with relapsing remitting multiple sclerosis.

Serum neurofilament light chain levels suggest neuroprotection following bexarotene-induced remyelination in people with relapsing remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: July 25, 2025

Ageing and remyelination failure in people with multiple sclerosis.

Ageing and remyelination failure in people with multiple sclerosis.

Journal: Brain : a journal of neurology

Published: April 22, 2025

The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy.

The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy.

Journal: Trials

Published: March 10, 2025

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.

Journal: Brain : a journal of neurology

Published: January 09, 2025

The Use of Musculoskeletal Fitness Measures as Indicators of Performance in Police Occupational Tasks.

The Use of Musculoskeletal Fitness Measures as Indicators of Performance in Police Occupational Tasks.

Journal: International journal of exercise science

Published: July 25, 2024

An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis.

An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis.

Journal: Annals of clinical and translational neurology

Published: July 12, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026